There is little that matters more to populations than their health. This has long made health a central concern for governments and policymakers worldwide, a substantial investment for both public and private sectors, and often a source of contention during politically divided times. And yet, the…
Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care
This Viewpoint focuses on the Manufacturer Discount Program, identifying 4 key themes of interest to policymakers that may be affected by its Part D redesign.
This economic evaluation investigates the cost-effectiveness of a cardiovascular polypill (single pill containing a statin and 3 half-standard dose antihypertensives) vs usual care in a…
This randomized clinical trial investigates whether a home-based mobile health cardiac rehabilitation intervention improves 6-minute walk distance in adults aged 65 years or older after…
Data from a follow-up at 6 months show a reduced risk of all-cause mortality in heart attack patients with anemia who receive a liberal transfusion…
This qualitative study develops the construct and collects examples of diagnostic pitfalls, defined as clinical situations and scenarios vulnerable to errors that may lead to…
Judicious prescribing is a prerequisite for safe and appropriate medication use. Based on evidence and lessons from recent studies demonstrating problems with widely prescribed medications,…
Tools and practical resources, aiming to educate researchers, promote integrity, and build trust in credible research and publications.
This cohort study compares the incidence of cardiovascular disease between Medicare beneficiaries with migraine who initiated anti–calcitonin gene-related peptide (CGRP) monoclonal antibodies compared with onabotulinumtoxinA.
This cohort study compares the incidence of cardiovascular disease between Medicare beneficiaries with migraine who initiated anti–calcitonin gene-related peptide (CGRP) monoclonal antibodies compared with onabotulinumtoxinA.
